“One study found that among people who had recovered from COVID-19, 100% had S protein-specific CD4+ T cells in the circulation and 70% had S protein-specific CD8+ T cells in the circulation (Grifoni et al. 2020).”
Despite knowing that people who had caught Covid had immunity to it, ATAGI still forced everyone to get the vaccine knowing it was ineffective and could cause injury.
Someone who tested positive to an antibody test for the S or N Covid protein were never granted an exemption.
Quote from: Page 9 of the TGA Non-clinical report.
Foreign Affairs, Defence and Trade Legislation Committee – 25/10/2023
Estimates – DEFENCE PORTFOLIO
Department of Defence
Senator RENNICK: I note that on page 9 of the Pfizer nonclinical report it was noted: One study found that among people who had recovered from COVID-19, 100% had S protein-specific CD4+ T cells in the circulation and 70% had S protein-specific CD8+ T cells in the circulation CD8+ T cells in the circulation (Grifoni et al. 2020). In other words, people had strong protection from COVID if they’d already caught it. Why were ATAGI still allowing or recommending that people who already had strong natural immunity get boosters, knowing that it could induce immune-imprinting or original antigenics in? The boosters were using different variants from the original strain to the original vaccines.
Prof. Crawford: The important thing to note is that when we initially rolled out the vaccines we didn’t have widespread infection in Australia, so the initial rollout was very limited episodes of infection, so for the majority that primary course was given in a very low population exposure. The ATAGI advice was always alluding to the potential risk-benefit of that vaccination program. After the omicron wave we did have widespread infection, and then we started talking about this combination of both infection and vaccination, which is hybrid immunity. The combination of those two has definitely meant there’s now a very high level of protection in the community, and we’re only recommending six-month booster vaccinations for those at highest risk. That includes over-75-year-olds and those in residential aged-care facilities, who have been mentioned in Senate estimates today. Essentially, specifically to your comments on the CD count, that’s the T-cell response. That’s not measured as frequently as the antibody response. Most of the data we get to see with the new vaccine products is antibody, specifically around neutralising antibody, which is a measure of how well you can clear infection. Those T-cell responses are definitely very important. Hopefully in the future we’ll have better markers that can tell us exactly what’s happening with those CD4 and CD8 cells, but at the time of most of our decision-making we didn’t have that data to hand. I do appreciate that we’re trying to work out a combination—
Senator RENNICK: I want to ask about the original—
CHAIR: I’m sorry. It’s time to adjourn, Senator Rennick.
